United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 1, 2014 | CEO | 9,066 | $101.84 | Sell | $923,281.44 | |
May 1, 2014 | EVP | 6,000 | $102.71 | Sell | $616,260.00 | |
May 1, 2014 | CFO | 10,000 | $102.20 | Sell | $1,022,000.00 | |
April 29, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
April 24, 2014 | CEO | 9,066 | $92.45 | Sell | $838,151.70 | |
April 22, 2014 | COO | 10,000 | $96.00 | Sell | $960,000.00 | |
April 17, 2014 | CEO | 9,066 | $98.48 | Sell | $892,819.68 | |
April 17, 2014 | CFO | 10,000 | $96.20 | Sell | $962,000.00 | |
April 17, 2014 | EVP | 6,000 | $98.37 | Sell | $590,220.00 | |
April 15, 2014 | COO | 10,000 | $95.06 | Sell | $950,600.00 | |
April 10, 2014 | CEO | 9,066 | $96.18 | Sell | $871,967.88 | |
April 8, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
April 4, 2014 | COO | 10,000 | $93.22 | Sell | $932,200.00 | |
April 3, 2014 | CEO | 9,066 | $93.74 | Sell | $849,846.84 | |
April 3, 2014 | Director | 1,500 | $95.67 | Sell | $143,505.00 | |
April 3, 2014 | CFO | 10,000 | $93.22 | Sell | $932,200.00 | |
April 3, 2014 | EVP | 6,000 | $93.10 | Sell | $558,600.00 | |
April 1, 2014 | COO | 10,000 | $95.44 | Sell | $954,400.00 | |
March 27, 2014 | CEO | 9,066 | $93.35 | Sell | $846,311.10 | |
March 25, 2014 | COO | 10,000 | $95.64 | Sell | $956,400.00 | |
March 21, 2014 | COO | 10,000 | $93.84 | Sell | $938,400.00 | |
March 20, 2014 | Director | 1,500 | $96.04 | Sell | $144,060.00 | |
March 20, 2014 | EVP | 6,000 | $96.81 | Sell | $580,860.00 | |
March 20, 2014 | CEO | 9,065 | $96.76 | Sell | $877,129.40 | |
March 20, 2014 | CFO | 10,000 | $96.11 | Sell | $961,100.00 | |
March 18, 2014 | COO | 10,000 | $96.51 | Sell | $965,100.00 | |
March 13, 2014 | CEO | 3,833 | $95.64 | Sell | $366,588.12 | |
March 7, 2014 | COO | 10,000 | $99.02 | Sell | $990,200.00 | |
March 6, 2014 | Director | 5,000 | $101.39 | Sell | $506,950.00 | |
March 6, 2014 | CEO | 3,833 | $102.77 | Sell | $393,917.41 | |
March 6, 2014 | EVP | 6,000 | $101.93 | Sell | $611,580.00 | |
March 6, 2014 | CFO | 10,000 | $99.07 | Sell | $990,700.00 | |
Feb. 28, 2014 | Director | 15,000 | $101.42 | Sell | $1,521,300.00 | |
Feb. 27, 2014 | CEO | 3,833 | $100.68 | Sell | $385,906.44 | |
Feb. 21, 2014 | COO | 10,000 | $104.89 | Sell | $1,048,900.00 | |
Feb. 20, 2014 | EVP | 6,000 | $104.63 | Sell | $627,780.00 | |
Feb. 20, 2014 | CEO | 3,833 | $103.91 | Sell | $398,287.03 | |
Feb. 13, 2014 | CEO | 3,833 | $99.87 | Sell | $382,801.71 | |
Feb. 7, 2014 | COO | 10,000 | $96.61 | Sell | $966,100.00 | |
Feb. 6, 2014 | EVP | 6,000 | $97.41 | Sell | $584,460.00 | |
Feb. 6, 2014 | CEO | 3,833 | $97.26 | Sell | $372,797.58 | |
Feb. 6, 2014 | Director | 3,000 | $97.33 | Sell | $291,990.00 | |
Jan. 30, 2014 | CEO | 3,833 | $106.25 | Sell | $407,256.25 | |
Jan. 23, 2014 | CEO | 3,833 | $111.78 | Sell | $428,452.74 | |
Jan. 17, 2014 | COO | 10,000 | $113.03 | Sell | $1,130,300.00 | |
Jan. 16, 2014 | EVP | 6,000 | $111.98 | Sell | $671,880.00 | |
Jan. 16, 2014 | CEO | 3,833 | $111.21 | Sell | $426,267.93 | |
Jan. 9, 2014 | Director | 5,000 | $110.00 | Sell | $550,000.00 | |
Jan. 9, 2014 | CEO | 3,833 | $108.35 | Sell | $415,305.55 | |
Jan. 3, 2014 | COO | 10,000 | $110.72 | Sell | $1,107,200.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.